Skip to main content
Clinical Trials/NCT06430723
NCT06430723
Completed
Not Applicable

Obesity and it's Impact on Subsidence and Clinical Outcomes After Short Stem Total Hip

Krankenhaus Barmherzige Schwestern Linz1 site in 1 country200 target enrollmentJanuary 1, 2018
ConditionsTHAObesity

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
THA
Sponsor
Krankenhaus Barmherzige Schwestern Linz
Enrollment
200
Locations
1
Primary Endpoint
Harris Hip Score
Status
Completed
Last Updated
last year

Overview

Brief Summary

The purpose of this study is to review the impact of obesity on subsidence and clinical outcome after short stem total hip arthroplasty.

Detailed Description

Short stem total hip arthroplasty (THA) has gained popularity due to its bone-sparing technique, but its outcomes in obese patients remain uncertain. While studies on the mid-term outcome in a general patient cohort provide excellent results in terms of the clinical and radiological outcome as well as the complication rate of short stem THA, data on its use in obese patients is still rare and not sufficiently conclusive. Some studies have found no evidence of increased subsidence in obese patients, while other studies have shown contrary trends. In this context, the aim of this study was to investigate the relationship between BMI, postoperative subsidence and clinical outcomes in the setting of short stem THA.

Registry
clinicaltrials.gov
Start Date
January 1, 2018
End Date
January 31, 2024
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Krankenhaus Barmherzige Schwestern Linz
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • patients who underwent primary short stem hip arthroplasty with Mathys Optimys short stem between 01.01.2018 and 31.12.2020
  • availability of preoperative and postoperative radiographs for assessment of subsidence
  • a minimum BMI of 30kg/m2 for the obese group
  • a minimum follow-up of 24 months.

Exclusion Criteria

  • former surgeries of the hip in question
  • incomplete clinical data
  • incomplete radiological data

Outcomes

Primary Outcomes

Harris Hip Score

Time Frame: 2 years

Clinical outcome, \[0-100points\]

Subsidence

Time Frame: 2 years

subsidence of the short stem measured via EBRA (Einzelbild Röntgenanalyse), \[mm\]

Secondary Outcomes

  • surgery time(2 years)
  • Length of stay(2 years)
  • Blood loss(2 years)

Study Sites (1)

Loading locations...

Similar Trials